2 results found

Maria Francesca Testa, Mirko Pinotti, Alessio Branchini, Maria Elisa Mancuso, Francesco Bernardi, Dario Balestra

Background: Among F8 mutation types, main determinants of inhibitor development after replacement therapy in Hemophilia A, nonsense mutations display wide variation in the associated risk. Molecular m...

Molecular Medicine 2026-04-23 rs-9414495
F8 PTCs Hemophilia A translational readthrough inhibitory antibody peptide MHCII affinity personalized medicine

SAYED ATHAR ALI HASHMI, Pushpendra Tiwari, Dr Naveen Datt Dixit

The rapid advancement of Artificial Intelligence of Things (AIoT) in smart pharmaceutics promises personalized and adaptive drug delivery systems with real-time monitoring and precise dosing. However,...

Research Square 2026-04-21 rs-9453234
Machine unlearning AIoT smart pharmaceutics privacy-preserving drug delivery cybersecurity digital twins personalized medicine
Back to Top
Home
Browse
Submit
About
0.028452s